Biomedical Imaging

The traditional methodology of identifying genetic mutations in cancer patients often relies on time-consuming processes that destroy precious biopsy samples before a treatment plan can even begin. This fundamental conflict between diagnostic necessity and sample preservation has led to the

For decades, the pursuit of a cure for Alzheimer’s disease has been defined by a series of high-profile clinical failures and a mounting sense of urgency as global populations age at an unprecedented rate. This persistent medical wall has historically been reinforced by the sheer volume of

The medical technology industry is currently undergoing a seismic shift, moving from reactive clinical treatments to proactive, home-based health management. Central to this transformation is the emerging field of neuro-metabolic monitoring, which seeks to understand the glymphatic system, the

The persistent challenge of treating metastatic castration-resistant prostate cancer has long centered on the tumor’s ability to remain invisible to the body’s natural immune defenses while resisting standard therapeutic interventions. A groundbreaking preclinical study led by researchers at Weill

The landscape of oncological care has shifted dramatically as researchers seek more precise ways to identify and eradicate malignant cells without damaging the healthy tissue surrounding them. Traditional methods of treating prostate cancer, while effective to an extent, often struggle with the

For more than a century, neurologists have known that the cognitive decay associated with multiple sclerosis stems from damage to the brain’s gray matter, yet these vital areas remained stubbornly invisible on conventional MRI scans until the arrival of sophisticated computational models. The